Common use of DUR Board Reporting Requirements Clause in Contracts

DUR Board Reporting Requirements. In accordance with IC 00-00-00-00, the DUR Board shall review the prescription drug programs of the Contractor at least one (1) time per year. This review shall include, but is not limited to, review of the following:  An analysis of the single source drugs requiring prior authorization in comparison to other contractor’s prescription drug programs in the Hoosier Healthwise program.  A determination and analysis of the number and the type of drugs subject to a restriction.  A review of the rationale for the prior authorization of a drug and a restriction on a drug.  A review of the number of requests a Contractor received for prior authorization, including the number of times prior authorization was approved and disapproved.  A review of patient and provider satisfaction survey reports and pharmacy-related grievance data for a twelve (12) month period.

DUR Board Reporting Requirements. In accordance with IC 00-00-00-00, the DUR Board shall review the prescription drug programs of the Contractor at least one (1) time per year. This review shall include, but is not limited to, review of the following:  ▪ An analysis of the single source drugs requiring prior authorization in comparison to other contractor’s prescription drug programs in the Hoosier Healthwise HIP program.  . ▪ A determination and analysis of the number and the type of drugs subject to a restriction.  ▪ A review of the rationale for the prior authorization of a drug and a restriction on a drug.  ▪ A review of the number of requests a Contractor received for prior authorization, including the number of times prior authorization was approved and disapproved.  ▪ A review of patient and provider satisfaction survey reports and pharmacy-related grievance data for a twelve (12) month period.. The Contractor shall provide OMPP with the information necessary for the DUR Board to

DUR Board Reporting Requirements. In accordance with IC 00-00-00-00, the DUR Board shall review the prescription drug programs of the Contractor at least one (1) time per year. This review shall include, but is not limited to, review of the following:  : 1. An analysis of the single source drugs requiring prior authorization in comparison to other contractor’s prescription drug programs in the Hoosier Healthwise PathWays program.  2. A determination and analysis of the number and the type of drugs subject to a restriction. 3.  A review of the rationale for the prior authorization of a drug and a restriction on a drug. 4.  A review of the number of requests a Contractor received for prior authorization, including the number of times prior authorization was approved and disapproved.  A review of patient and provider satisfaction survey reports and pharmacy-related grievance data for a twelve (12) month period.